Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

著者: Peter A. Calabresi, Ernst-Wilhelm Radüe, Douglas S. Goodin, Douglas Jeffery, Kottil Rammohan, Anthony T. Reder, Timothy Vollmer, Mark Agius, Ludwig Kappos, Tracy Stites, Bingbing Li, Linda Cappiello, Philipp von Rosenstiel, Fred Lublin - The Lancet 2014 被引用: 822